Previous studies have suggested that the human leukocyte antigen (HLA) is involved in the etiology of Crohn's disease (CD); however, few reports are available on the association between HLA class I antigens and CD in Japan. In this study, we performed association analysis of HLA class I antigens in CD using 208 Japanese patients and 384 healthy controls. We identified novel positive associations between CD and HLA-A*02:01 (odds ratio (OR) = 1.64, P = 0.016) and HLA-A*02:07 (OR = 2.31, P = 0.0067) and confirmed previously reported positive associations between CD and HLA-Cw*14:02 (OR = 2.18, P = 0.0021) and HLA-B*51:01 (OR = 1.70, P = 0.033). We also identified novel negative associations between CD and HLA-A*24:02 (OR = 0.60, P = 0.0047) and HLA-B*07:02 (OR = 0.38, P = 0.0041). Although the associations were not significant after full Bonferroni correction, we suggested that HLA class I genes have dual functions, susceptibility and resistance in controlling the development of CD.
INTRODUCTION
Crohn's disease (CD) and ulcerative colitis, two main subtypes of inflammatory bowel disease, are chronic and relapsing inflammatory disorders of the gastrointestinal tract caused by an aberrant response of the intestinal immune system to commensal bacteria. 1, 2 CD affects all regions of the gastrointestinal tract, most commonly the ileum and colon, whereas the inflammation in ulcerative colitis is confined to the colon. The pathological changes in CD are typically discontinuous and often transmural. By contrast, those in ulcerative colitis are continuous and confined to the mucosa and submucosa. 2 Although the prevalence of CD is lower (23.6/100 000 persons) in Japan compared with European populations, it has been increasing continuously over the past several decades in Japan and other Asian countries. 3 Although their exact etiology remains unclear, genetic factors appear to contribute to the susceptibility to these diseases. The genetic component seems stronger in CD than in ulcerative colitis. 4 A statistically significant association of human leukocyte antigen (HLA) with CD has been widely reported, especially for the HLA class II antigens; [5] [6] [7] [8] [9] reports of this association include a metaanalysis by Stokkers et al. 10 However, the data from these analyses should be interpreted with caution because they include data from both serological and molecular typing of HLA, as well as studies on different ethnic groups. There have been a few reports on the association of HLA class I alleles with CD in the Japanese population; however, there have been no reports specifically on the association of HLA-A alleles with CD in Japan. To elucidate the role of HLA class I antigens in the etiology of CD, we investigated the genetic association between the HLA-A, -C and -B alleles and CD in this study.
RESULTS

Association of HLA class I antigens with CD
We analyzed 10 HLA-A, 12 HLA-C and 18 HLA-B alleles with frequencies 41.0%. Compared with the controls, the antigen frequencies of HLA-A*02:01 (odds ratio (OR) = 1.64, P = 0.016), HLA-A*02:07 (OR = 2.31, P = 0.0067), HLA-Cw*14:02 (OR = 2.18, P = 0.0021), HLA-B*46:01 (OR = 1.88, P = 0.018) and HLA-B*51:01 (OR = 1.70, P = 0.033) were increased in patients with CD, whereas the antigen frequencies of HLA-A*24:02 (OR = 0.60, P = 0.0047) and HLA-B*07:02 (OR = 0.38, P = 0.0041) were decreased (Table 1) . Thus, we identified three novel susceptibility alleles for CD, HLA-A*02:01, HLA-A*02:07 and HLA-B*46:01, and we confirmed two previously reported susceptibility alleles for CD, HLA-Cw*14:02 and HLA-B*51:01. 11 Furthermore, we identified two novel protective alleles for CD, HLA-A*24:02 and HLA-B*07:02. However, it should be noted that these associations were not statistically significant after Bonferroni correction. Therefore, the associations newly found in our study need to be replicated using another sample set in future study.
Among the three novel susceptibility alleles, linkage disequilibrium (LD) is known to occur between HLA-A*02:07 and HLA-B*46:01 in the Japanese population. Conditional analyses showed that HLA-A*02:07 affected the strength of the association between HLA-B*46:01 and CD and vice versa ( Table 2 ). This observation, along with the fact that the association for HLA-A*02:07 was more significant than the association for HLA-B*46:01 in the nonconditional analysis ( Table 1) , suggests that HLA-A*02:07 is the primary susceptibility allele for CD.
The novel protective alleles, HLA-A*24:02 and HLA-B*07:02, are also known to be in LD in the Japanese population. However, we observed that the associations between these alleles and CD were still significant even when conditioned on each other ( Table 2 ).
This observation suggests that HLA-A*24:02 and HLA-B*07:02 are independent protective HLA class I alleles for CD. In conclusion, we identified HLA-A*02:01 and HLA-A*02:07 as novel HLA class I susceptibility alleles for CD and HLA-A*24:02 and HLA-B*07:02 as HLA class I protective alleles for CD.
LD structure between HLA-A*24:02, HLA-Cw*14:02 and HLA-B*51:01 Although we found the HLA-A*24:02 allele to be protective and the HLA-Cw*14:02 and HLA-B*51:01 alleles to be associated with susceptibility for CD, these alleles constitute a common HLA haplotype in the Japanese population. Therefore, we investigated the differences in the degree of LD among these alleles between the CD and control groups. As shown in Figure 1 , moderate or strong LDs were observed between HLA-A*24:02 and HLA-Cw*14:02 (D′ = 0.36), between HLA-A*24:02 and HLA-B*51:01 (D′ = 0.51) and between HLA-Cw*14:02 and HLA-B*51:01 (D′ = 0.97) in the control group. In contrast, although the LD between HLA-Cw*14:02 and HLA-B*51:01 was at the same level (D′ = 0.97) in the CD group, the LDs between HLA-A*24:02 and HLA-Cw*14:02 and those between HLA-A*24:02 and HLA-B*51:01 were weaker in the CD group (D′ = 0.13 and 0.06, respectively) than in the controls. These results suggest that the HLA-A*24:02-Cw*14:02-B*51:01 haplotype carries unobserved variant adjacent to HLA-A*24:02, which contributes to a protective effect on CD.
DISCUSSION
In our study, novel positive associations between the HLA-A*02:01 and HLA-A*02:07 alleles and CD were identified. Likewise, a serologically defined HLA-A2 allele has been previously identified as a significant susceptibility allele for CD in Caucasians. 12 Therefore, we analyzed the total frequency of all HLA-A*02 subtypes that were increased in CD, which included HLA-A*02:01, HLA-A*02:06 and HLA-A*02:07 (OR = 1.92, P = 3.8 × 10 −4 ) ( Table 1) .
Among the HLA-A*02 alleles, HLA-A*02:07 was more strongly associated with CD than was HLA-A*02:01, and HLA-A*02:06 did not exhibit a significant positive association. To explain these differences, we compared the amino acid sequences of each HLA-A*02 allele subtype. There is a polymorphic change from phenylalanine to tyrosine at amino acid position 9 in the HLA-A*02:06 allele compared with the susceptibility alleles HLA-A*02:01 and HLA-A*02:07, which is not associated with CD susceptibility, and a change from cysteine to tyrosine at position 99 in HLA-A*02:01 compared with HLA-A*02:07 (Table 3) . 13 It has been reported that the amino acids at positions 9 and 99 in HLA-A2 comprise the contact residues of the peptide binding pocket B. In these amino acid changes, the increased hydrophobicity of the residues at positions 9 and 99 has a greater effect on the susceptibility to CD (hydropathy index: phenylalanine 2.8, tyrosine −1.3, cysteine 2.5). The analysis of the amino acid changes among the HLA-A*02:01, HLA-A*02:06 and HLA-A*02:07 alleles suggests the following: (i) The phenylalanine at position 9 in HLA-A*02 is critical to determine the susceptibility to CD. (ii) The change from cysteine to tyrosine at position 99 weakens the susceptibility to CD. In addition, HLA-A*02:01 and HLA-A*02:07 have been reported to bind peptides with leucine/ methionine and leucine residues, respectively, at position 2, which is buried deep within peptide binding pocket B, 14, 15 whereas HLA-A*02:06 accommodates binding to valine/glutamine residues at position 2. These differences may also affect disease susceptibility to CD.
In summary, we identified two novel susceptibility HLA class I alleles, HLA-A*02:01 and HLA-A*02:07, and two protective alleles, HLA-A*24:02 and HLA-B*07:02, for CD in the Japanese population, although the association signals were not significant after full Bonferroni correction. It was suggested that the susceptibility conferred by the HLA-A*02 alleles might be due to the polymorphic amino acid changes in these alleles that occur within pocket B in the antigen binding groove of the HLA-A2 molecule. All these findings may suggest a direct involvement of the HLA class I molecule in the susceptibility and resistance to CD by regulating the immune response in the gastrointestinal region.
MATERIALS AND METHODS Subjects
Unrelated Japanese individuals with CD and healthy controls (208 and 384 individuals, respectively) were enrolled in this study. The CD diagnoses were made by gastroenterologists using conventional endoscopic, histologic and clinical criteria. Patients with indeterminate colitis were excluded in advance. Documented informed consent was obtained from each participant according to the Declaration of Helsinki. This study was also approved by the Ethics Committee at Kyushu University, Keio University and Tokyo Medical and Dental University in Japan.
Genotyping of HLA alleles
We determined the HLA-A, HLA-C and HLA-B genotypes (4-digit) using the Luminex assay system (Luminex Corporation, Austin, TX, USA) and HLA typing kits (Wakunaga, Hiroshima, Japan). We observed a total of 79 alleles (HLA-A: 21, HLA-C: 18 and HLA-B: 40 alleles). The HLA alleles with a frequency 40.01 (HLA-A: 10, HLA-C: 12 and HLA-B: 18 alleles) were subjected to further analyses.
Statistical analysis
The association between CD and the HLA class I antigen was assessed by logistic regression analysis with an allele dominant model adjusted for sex. For the conditional analysis, the indicated HLA class I allele was included in the independent variable. The P-values and ORs were computed using PLINK version 1.07 software (http://pngu.mgh.harvard.edu/purcell/plink/). 16 The LD among the HLA alleles (HLA-A*24:02, HLA-Cw*14:02 and HLA-B*51:01) was calculated using Haploview version 4.2 software (http://www. broadinstitute.org/scientific-community/science/programs/medical-andpopulation-genetics/haploview/haploview). 17 Table 3 . Polymorphic amino acid changes among HLA-A*02 alleles.
HLA-A*02
Polymorphic residue positions 9 99 149 152 156 A*02:01
The residues that are different among the three alleles are shown in bold face.
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